Wednesday, May 6, 2015
Arno Therapeutics receives European orphan drug designation for AR-12 to treat two infectious diseases
Arno Therapeutics, Inc., a clinical stage biopharmaceutical company primarily focused on the development of therapeutics for the treatment of cancer and other life threatening diseases, today...http://www.medicalnewstoday.com/releases/293498.php
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.